Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
Addex Therapeutics Ltd (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, focused on discovering and developing innovative…
Browsing Tag